N2G校准器:一个跨学科领域的对抗性培训框架,用于在帕金森病中从神经信号跟踪步态
medRxiv : the preprint server for health sciences
|November 24, 2025
概括
这项研究引入了一个新的深度学习框架,用于帕金森病患者使用集体神经数据跟踪步态. 它使个性化模型能够在没有广泛的个人数据收集的情况下实现个性化模型,改善了适应性深度大脑刺激的可访问性.
科学领域:
- 生物医学工程 生物医学工程
- 神经科学是一个神经科学.
- 机器学习 机器学习
背景情况:
- 适应性深度大脑刺激 (DBS) 依赖于机器学习模型来解释用于运动状态跟踪的神经信号.
- 目前的数据驱动的DBS方法需要广泛的,用户特定的数据收集,包括重复的任务和传感器,由于个体间的神经信号的变化.
- 这限制了个性化的模型校准,特别是在临床环境之外.
研究的目的:
- 开发一个跨学科的深度学习框架,神经到步态校准器,用于跟踪帕金森病患者的步态表现.
- 消除对广泛的用户特定数据和同步步行程记录系统的需求,以进行个性化的模型校准.
- 为了使个性化的模型校准在设备齐全的临床环境之外.
主要方法:
- 利用跨学科的深度学习框架,利用来自多个个体的集体神经数据.
- 采用域对抗式学习来校准目标用户的神经信号,使用来自其他个人的数据.
- 验证了框架在追踪PD患者的步行表现方面的有效性.
主要成果:
- 与没有校准训练的模型相比,实现了显著的错误率降低.
- 证明了与直接使用标记目标数据训练的模型可比的性能.
- 成功启用了个性化的模型校准,而不需要同步步行记录.
结论:
- 神经到步态校准器框架有效地跟踪PD患者的步态表现,使用集体神经数据.
- 域对抗式学习促进了跨主题校准,减少了对广泛的个人数据收集的需求.
- 这种方法通过在临床环境之外进行校准来提高个性化自适应DBS的可行性.
更多相关视频
06:25Paw-Print Analysis of Contrast-Enhanced Recordings PrAnCER: A Low-Cost, Open-Access Automated Gait Analysis System for Assessing Motor Deficits
Published on: August 12, 2019
9.0K
06:54Clinical-oriented Three-dimensional Gait Analysis Method for Evaluating Gait Disorder
Published on: March 4, 2018
14.7K
相关概念视频
Parkinson's Disease: Treatment
953
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
953
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
